Blazquez J, Couce A, Rodriguez-Beltran J, Rodriguez-Rojas A: Antimicrobials as promoters of genetic variation. Curr Opin Microbiol. 2012, 15: 561-569. 10.1016/j.mib.2012.07.007.
Article
CAS
Google Scholar
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II, Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009, 302: 2323-2329. 10.1001/jama.2009.1754.
Article
CAS
Google Scholar
Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P, Felleiter P, Engoren M, Vincent JL, EPIC II, Group of Investigators: Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents. 2011, 38: 331-335. 10.1016/j.ijantimicag.2011.05.013.
Article
CAS
Google Scholar
Antibiotic resistance threats in the United States. [http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf]
Espadinha D, Faria NA, Miragaia M, Lito LM, Melo-Cristino J, de Lencastre H: Extensive dissemination of methicillin-resistant Staphylococcus aureus (MRSA) between the hospital and the community in a country with a high prevalence of nosocomial MRSA. PLoS One. 2013, 8: e59960-10.1371/journal.pone.0059960.
Article
CAS
Google Scholar
Goncalves-Pereira J, Pereira JM, Ribeiro O, Baptista JP, Froes F, Paiva JA: Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit - The INFAUCI study. Clin Microbiol Infect 2014. doi:10.1111/1469-0691.12738.,
DiMondi VP, Rafferty K: Review of continuous-infusion vancomycin. Ann Pharmacother. 2013, 47: 219-227. 10.1345/aph.1R420.
Article
Google Scholar
Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, Thomas F, Timsit JF, Similowski T, Mentec H, Mier L, Dreyfuss D: Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother. 2001, 45: 2460-2467. 10.1128/AAC.45.9.2460-2467.2001.
Article
CAS
Google Scholar
Cataldo MA, Tacconelli E, Grilli E, Pea F, Petrosillo N: Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother. 2012, 67: 17-24. 10.1093/jac/dkr442.
Article
CAS
Google Scholar
Rello J, Sole-Violan J, Sa-Borges M, Garnacho-Montero J, Munoz E, Sirgo G, Olona M, Diaz E: Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit Care Med. 2005, 33: 1983-1987. 10.1097/01.CCM.0000178180.61305.1D.
Article
CAS
Google Scholar
Hutschala D, Kinstner C, Skhirdladze K, Thalhammer F, Muller M, Tschernko E: Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion. Anesthesiology. 2009, 111: 356-365. 10.1097/ALN.0b013e3181a97272.
Article
CAS
Google Scholar
Baptista JP, Sousa E, Martins PJ, Pimentel JM: Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents. 2012, 39: 420-423. 10.1016/j.ijantimicag.2011.12.011.
Article
CAS
Google Scholar
Ocampos-Martinez E, Penaccini L, Scolletta S, Abdelhadii A, Devigili A, Cianferoni S, de Backer D, Jacobs F, Cotton F, Vincent JL, Taccone FS: Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Int J Antimicrob Agents. 2012, 39: 332-337. 10.1016/j.ijantimicag.2011.12.008.
Article
CAS
Google Scholar
Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D: Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis. Intensive Care Med. 2013, 39: 1247-1252. 10.1007/s00134-013-2909-9.
Article
CAS
Google Scholar
Udy AA, Roberts JA, Lipman J: Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med. 2013, 39: 2070-2082. 10.1007/s00134-013-3088-4.
Article
CAS
Google Scholar
Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP: Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009, 49: 325-327. 10.1086/600877.
Article
Google Scholar
Rowland M, Tozer TN: Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 4th edition. Philadelphia: Wolters Kluwer Health/Lippincott William & Wilkins; 2010. c2011.
Pea F, Furlanut M, Negri C, Pavan F, Crapis M, Cristini F, Viale P: Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother. 2009, 53: 1863-1867. 10.1128/AAC.01149-08.
Article
CAS
Google Scholar
Lamer C, de Beco V, Soler P, Calvat S, Fagon JY, Dombret MC, Farinotti R, Chastre J, Gibert C: Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother. 1993, 37: 281-286. 10.1128/AAC.37.2.281.
Article
CAS
Google Scholar
Inker LA, Perrone RD: Assessment of Kidney Function. In UpToDate. Edited by Sterns RH, Post TW. 2013. Waltham, MA. http://www.uptodate.com/contents/assessment-of-kidney-function?source=search_result&search=Assessment+of+Kidney+Function.&selectedTitle=1~150.
Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, Lipman J: A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care. 2011, 15: R139-10.1186/cc10262.
Article
Google Scholar
Bragadottir G, Redfors B, Ricksten SE: Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury - true GFR versus urinary creatinine clearance and estimating equations. Crit Care. 2013, 17: R108-10.1186/cc12777.
Article
Google Scholar
Baptista JP, Neves M, Rodrigues L, Teixeira L, Pinho J, Pimentel J: Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients. J Nephrol. 2014, 27: 403-410. 10.1007/s40620-013-0036-x.
Article
Google Scholar
Udy AA, Baptista JP, Lim NL, Joynt GM, Jarrett P, Wockner L, Boots RJ, Lipman J: Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically Ill patients with normal plasma creatinine concentrations*. Crit Care Med. 2014, 42: 520-527. 10.1097/CCM.0000000000000029.
Article
CAS
Google Scholar
Claus BO, Hoste EA, Colpaert K, Robays H, Decruyenaere J, De Waele JJ: Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013, 28: 695-700. 10.1016/j.jcrc.2013.03.003.
Article
CAS
Google Scholar
Loirat P, Rohan J, Baillet A, Beaufils F, David R, Chapman A: Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin. N Engl J Med. 1978, 299: 915-919. 10.1056/NEJM197810262991703.
Article
CAS
Google Scholar
Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA: Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest. 2012, 142: 30-39. 10.1378/chest.11-1671.
Article
CAS
Google Scholar
Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Eliopoulos GM: Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004, 42: 2398-2402. 10.1128/JCM.42.6.2398-2402.2004.
Article
CAS
Google Scholar
Blot SKD, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, Roberts JA: Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI Study. Critical Care: Bio Med Central. 2014, 18: R99-10.1186/cc13874.
Article
Google Scholar
Saugel B, Gramm C, Wagner JY, Messer M, Lahmer T, Meidert AS, Schmid RM, Huber W: Evaluation of a dosing regimen for continuous vancomycin infusion in critically ill patients: An observational study in intensive care unit patients. J Crit Care. 2014, 29: 351-355. 10.1016/j.jcrc.2013.12.007.
Article
CAS
Google Scholar
Jeurissen A, Sluyts I, Rutsaert R: A higher dose of vancomycin in continuous infusion is needed in critically ill patients. Int J Antimicrob Agents. 2011, 37: 75-77. 10.1016/j.ijantimicag.2010.09.004.
Article
CAS
Google Scholar
De Waele JJ, Danneels I, Depuydt P, Decruyenaere J, Bourgeois M, Hoste E: Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion. Int J Antimicrob Agents. 2013, 41: 434-438. 10.1016/j.ijantimicag.2012.12.015.
Article
CAS
Google Scholar
Dailly E, Le Floch R, Deslandes G, Pannier M, Jolliet P: Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients. Int J Antimicrob Agents. 2008, 31: 537-539. 10.1016/j.ijantimicag.2008.02.008.
Article
CAS
Google Scholar
Kees MG, Hilpert JW, Gnewuch C, Kees F, Voegeler S: Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents. 2010, 36: 545-548. 10.1016/j.ijantimicag.2010.07.015.
Article
CAS
Google Scholar
Roberts JATF, Udy AA, Vincent JL, Jacobs F, Lipman J: Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother. 2011, 55: 2704-2709. 10.1128/AAC.01708-10.
Article
CAS
Google Scholar
Beumier M, Roberts JA, Kabtouri H, Hites M, Cotton F, Wolff F, Lipman J, Jacobs F, Vincent JL, Taccone FS: A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy. J Antimicrob Chemother. 2013, 68: 2859-2865. 10.1093/jac/dkt261.
Article
CAS
Google Scholar
Udy AA, Morton FJ, Nguyen-Pham S, Jarrett P, Lassig-Smith M, Stuart J, Dunlop R, Starr T, Boots RJ, Lipman J: A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations. BMC Nephrol. 2013, 14: 250-10.1186/1471-2369-14-250.
Article
Google Scholar